
Retatrutide 15mg Research Vial
Retatrutide 15mg is a lyophilised research peptide supplied as a single, sealed vial for metabolic receptor studies in vitro.
Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.

Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.
Price shown is for a single 10mg vial. The final amount is confirmed at checkout. Need a different amount? Send an inquiry.
Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling. Retatrutide is a synthetic peptide investigated for activity at three receptor pathways involved in energy balance. The 10mg vial is the smallest strength in the range, which makes it a practical choice for pilot experiments and small-scale assay work where material is limited. It arrives as a freeze-dried powder, sealed under clean conditions and labelled with its nominal 10mg content. The batch report linked on this page records the identity and purity measured for the specific lot, including the CAS number 2381089-83-2. Like every material in the AthloPep catalogue, this vial is intended for laboratory research only and is not a medicine. This listing is for the 10mg vial. The material is identified by CAS number 2381089-83-2. The current batch report records a measured purity of 99.493%.
| Labelled amount | 10mg |
|---|---|
| Form | Lyophilised powder |
| CAS number | 2381089-83-2 |
| Intended use | In vitro laboratory research |
Every vial is supplied with an analytical report prepared for its own batch. The report records identity and purity results for the submitted sample. Match the batch identifier on the report to the vial you receive before use.
Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling. It is supplied as a lyophilised, sealed research vial and is not a medicine.
The vial is labelled with a nominal 10mg of material. The figure is the stated content of the vial, not a solution concentration, and should be checked against the batch documentation before use.
Yes. Each listing links to the analytical report prepared for the specific batch. The report records identity and purity results for the submitted sample and should be matched to the vial you receive.
It arrives as a freeze-dried powder in a sealed vial. Keep the container closed and follow the storage conditions printed on the label and any handling sheet supplied with the lot.
No. AthloPep supplies this material for in vitro laboratory research only. It is not for human or animal consumption and no therapeutic use is implied.
The listed unit price for this vial is $95.7. Prices are shown in US dollars and the final amount is confirmed on the checkout page before payment.

Retatrutide 15mg is a lyophilised research peptide supplied as a single, sealed vial for metabolic receptor studies in vitro.

Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways.

Retatrutide 30mg is a sealed, lyophilised research vial for in vitro work on metabolic receptor signalling.

Retatrutide 40mg is a lyophilised research peptide supplied in a sealed vial for higher-volume in vitro metabolic studies.
Tell us what you need. An email address is required so we can reply.